PT1107795E - Tiomolibdato associado com pelo menos um hidrato de carbono e o seu uso para evitar ou tratar doencas caracterizadas por uma vascularizacao tais como cancro degeneracao macular do tipo humido artrite reumatoide - Google Patents
Tiomolibdato associado com pelo menos um hidrato de carbono e o seu uso para evitar ou tratar doencas caracterizadas por uma vascularizacao tais como cancro degeneracao macular do tipo humido artrite reumatoideInfo
- Publication number
- PT1107795E PT1107795E PT99952903T PT99952903T PT1107795E PT 1107795 E PT1107795 E PT 1107795E PT 99952903 T PT99952903 T PT 99952903T PT 99952903 T PT99952903 T PT 99952903T PT 1107795 E PT1107795 E PT 1107795E
- Authority
- PT
- Portugal
- Prior art keywords
- cancer
- tiomolibdate
- vascularization
- avoid
- rheumatoid arthritis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9910398P | 1998-09-04 | 1998-09-04 | |
| US10175998P | 1998-09-25 | 1998-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1107795E true PT1107795E (pt) | 2003-04-30 |
Family
ID=26795562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99952903T PT1107795E (pt) | 1998-09-04 | 1999-09-03 | Tiomolibdato associado com pelo menos um hidrato de carbono e o seu uso para evitar ou tratar doencas caracterizadas por uma vascularizacao tais como cancro degeneracao macular do tipo humido artrite reumatoide |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1107795B1 (pt) |
| JP (1) | JP2002524426A (pt) |
| KR (1) | KR100702279B1 (pt) |
| CN (1) | CN100548383C (pt) |
| AT (1) | ATE228375T1 (pt) |
| AU (1) | AU773848B2 (pt) |
| CA (1) | CA2341752A1 (pt) |
| DE (1) | DE69904203T2 (pt) |
| DK (1) | DK1107795T3 (pt) |
| ES (1) | ES2188261T3 (pt) |
| IL (1) | IL141550A0 (pt) |
| NZ (1) | NZ510038A (pt) |
| PT (1) | PT1107795E (pt) |
| WO (1) | WO2000013712A2 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6703050B1 (en) | 1998-09-04 | 2004-03-09 | The Regents Of The University Of Michigan | Methods and compositions for the prevention or treatment of cancer |
| US20070292533A1 (en) * | 2002-05-24 | 2007-12-20 | Regents Of The University Of Michigan | Copper lowering treatment of autoimmune diseases |
| EP1531827A4 (en) * | 2002-05-24 | 2009-07-08 | Univ Michigan | COPPER-REDUCING TREATMENT FOR INFLAMMATORY AND FIBROTIC DISEASES |
| US7189865B2 (en) * | 2002-07-23 | 2007-03-13 | Attenuon, Llc | Thiomolybdate analogues and uses thereof |
| AU2003261222B2 (en) | 2002-07-23 | 2009-07-09 | The Regents Of The University Of Michigan | Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| US7851505B2 (en) | 2003-05-27 | 2010-12-14 | Attenuon, Llc | Thiotungstate analogues and uses thereof |
| AU2005217623A1 (en) * | 2004-02-24 | 2005-09-09 | Attenuon Llp | Inhibition of superoxide dismutase by tetrathiomolybdate: identification of new anti-angiogenic and antitumor agents |
| CA2675230A1 (en) * | 2006-01-10 | 2008-07-26 | Pipex, Inc. | Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| WO2009009622A2 (en) * | 2007-07-09 | 2009-01-15 | Pipex Pharmaceuticals, Inc. | Pharmaceutical compositions, including attm, and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| KR100972355B1 (ko) * | 2008-05-08 | 2010-07-26 | 고려전자주식회사 | 순간식 가스보일러의 온수공급라인용 써모밸브조립체 |
| US10478455B2 (en) | 2010-03-30 | 2019-11-19 | Ucl Business Ltd | Therapeutic use of tetrathiomolybdate |
| GB201005394D0 (en) * | 2010-03-30 | 2010-05-12 | Magnus Intellectual Property Ltd | Therapy |
| US20160220500A1 (en) * | 2014-11-14 | 2016-08-04 | Kent State University | Targeting Intracellular Copper Ions for Inhibiting Angiogenesis Using Nanoparticles of Ternary Inorganic Metal Sulfide M1M2S4 (M1, independently, is Mg, Ca, Mn, Fe, or Zn; M2 = Mo or W) Compounds to Treat Metastatic Cancer |
| CN108634322A (zh) * | 2018-05-16 | 2018-10-12 | 刘华 | 一种预防和调理癌症的方法 |
-
1999
- 1999-09-03 PT PT99952903T patent/PT1107795E/pt unknown
- 1999-09-03 NZ NZ510038A patent/NZ510038A/en not_active IP Right Cessation
- 1999-09-03 DE DE69904203T patent/DE69904203T2/de not_active Expired - Lifetime
- 1999-09-03 KR KR1020017002840A patent/KR100702279B1/ko not_active IP Right Cessation
- 1999-09-03 IL IL14155099A patent/IL141550A0/xx unknown
- 1999-09-03 CA CA002341752A patent/CA2341752A1/en not_active Abandoned
- 1999-09-03 WO PCT/US1999/020374 patent/WO2000013712A2/en active IP Right Grant
- 1999-09-03 CN CNB998117331A patent/CN100548383C/zh not_active Expired - Fee Related
- 1999-09-03 DK DK99952903T patent/DK1107795T3/da active
- 1999-09-03 AU AU64960/99A patent/AU773848B2/en not_active Ceased
- 1999-09-03 JP JP2000568518A patent/JP2002524426A/ja active Pending
- 1999-09-03 EP EP99952903A patent/EP1107795B1/en not_active Expired - Lifetime
- 1999-09-03 AT AT99952903T patent/ATE228375T1/de not_active IP Right Cessation
- 1999-09-03 ES ES99952903T patent/ES2188261T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NZ510038A (en) | 2003-10-31 |
| AU6496099A (en) | 2000-03-27 |
| EP1107795A2 (en) | 2001-06-20 |
| JP2002524426A (ja) | 2002-08-06 |
| ES2188261T3 (es) | 2003-06-16 |
| DE69904203D1 (de) | 2003-01-09 |
| CA2341752A1 (en) | 2000-03-16 |
| WO2000013712A2 (en) | 2000-03-16 |
| WO2000013712A3 (en) | 2000-09-28 |
| DK1107795T3 (da) | 2003-03-24 |
| KR100702279B1 (ko) | 2007-04-02 |
| IL141550A0 (en) | 2002-03-10 |
| DE69904203T2 (de) | 2003-08-14 |
| AU773848B2 (en) | 2004-06-10 |
| EP1107795B1 (en) | 2002-11-27 |
| ATE228375T1 (de) | 2002-12-15 |
| CN1457261A (zh) | 2003-11-19 |
| KR20010082190A (ko) | 2001-08-29 |
| CN100548383C (zh) | 2009-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267381A (en) | A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders | |
| PT1107795E (pt) | Tiomolibdato associado com pelo menos um hidrato de carbono e o seu uso para evitar ou tratar doencas caracterizadas por uma vascularizacao tais como cancro degeneracao macular do tipo humido artrite reumatoide | |
| BRPI0409919A (pt) | combinações para o tratamento de doenças envolvendo proliferação, migração ou apoptose celular de células de células de mieloma, ou angiogênese | |
| DE60216139D1 (de) | Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen | |
| IL180725A0 (en) | Inhibitors of angiopoietin-like 4 protein, combinations, and their use | |
| MX2007004551A (es) | Compuestos tiadiazol y metodos de uso. | |
| BRPI0518567A2 (pt) | composiÇço farmacÊutica, usos de uma composiÇço farmacÊutica, de sabcomelina ou um sal farmaceuticamente aceitÁvel da mesma, de pelo menos um agente neurolÉptico e de uma combinaÇço de sabcomelina ou um sal farmaceuticamente aceitÁvel da mesma e pelo menos um agente neurolÉptico, kit de partes para uso no tratamento de um dustérbio psicàtico, mÉtodo de tratamento de um distérbio psicàtico, e, sabcomelina ou um sal farmaceuticamente aceitÁvel da mesma | |
| EA200600921A1 (ru) | Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний | |
| TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
| EP0281070A3 (en) | Pharmaceutical composition for the treatment of cancer | |
| MXPA02000680A (es) | Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf. | |
| MXPA00010254A (es) | Tratamiento de disfuncion sexual en ciertos grupos de pacientes. | |
| HK1074840A1 (en) | Novel dithiolopyrrolones with therapeutic activity | |
| EP1234585A3 (en) | Methods and compositions for the prevention or treatment of cancer | |
| DE602004019135D1 (de) | Screeningverfahren für Kombinationen von biologischen Verbindungen | |
| PT1103270E (pt) | Tratamento de doencas auto-imunes em mamiferos |